In contrast to reports indicating that DRP1 activity is necessary for proper cell cycle progression (75, 76) and tumor growth (8, 18, 58), the growth rate of sarcoma cells was unaffected by reduced DRP1 levels (Figs 5B and F, S8, and S9). Here, DNM1L is linked to sarcoma.